Sign in to continue:

Friday, February 13th, 2026

Category: Hong Kong stocks

New World Seals $11.2B Lifeline; UMS Eyes Malaysia Debut; Dezign Format Joins IPO Race; SingTel CEO Sees Payday Surge

HK:0017.HK:New World Development Distressed Hong Kong developer New World Development has finalized a HK$88.2 billion (US$11.2 billion) refinancing deal, marking the city’s largest-ever refinancing transaction. The firm, controlled by tycoon Henry Cheng, secured 100%...

Anjoy Foods Raises HK$2.6B in Dual-Listed IPO, Retail Demand Hits 92×, Targets 75–85 HK$ Listing Range

IPO Details Purpose of IPOAnjoy Foods plans to raise HKD 2.64 billion by offering approximately 40 million H-shares at HKD 66 each. Use of proceeds: 35% for expanding sales and distribution networks, 35% for...

Cloudbreak‑B Raises HKD 612M in Ophthalmic Biotech IPO—Cornerstone Backing, R&D Boost Targeted for Visual Therapy Pipeline

IPO Details Purpose of IPOCloudbreak‑B is seeking to raise approximately HKD 612 million by issuing 60.582 million shares at HKD 10.10. Net proceeds (~HKD 522 million) will be allocated to: R&D and clinical development, Expansion of manufacturing...

Unisound AI IPO Priced at HKD 205, But Cools Ahead of HKEX Debut—Flat to Modest Listing Expected

IPO Details Purpose of IPOAims to raise up to HKD 320 million through the issuance of 1.56 million H-shares, priced between HKD 165–205. Proceeds will fund: Scaling of the Atlas AI infrastructure, Expansion of...

IFBH Coconut Water IPO Soaks Up HK$314B in Demand, Soars 65% in Grey Market—Will It Quench Investors’ Thirst?

IPO Details Purpose of IPOIFBH aims to raise funds to support its coconut-water beverage business, focusing on expanding production capacity and scaling operations globally. The IPO is clearly growth-driven, although exact allocations are pending...

Medtide Launches HK$514m IPO at Top of Range—U.S./China Expansion to Propel Peptide CDMO #3 in High-Growth GLP-1 Market

1. IPO Details Purpose of IPOMedtide plans to raise up to HKD 514 million (~USD 65.5 million), with proceeds allocated as follows: 76.4% for new peptide and oligonucleotide production facilities in the U.S. and China (including a...

💥 IPO Frenzy, Data Centre Plays & STI Surge: Asia Markets Heat Up Amid Falling Yields and AI Optimism

💥 IPO Frenzy, Data Centre Plays & STI Surge: Asia Markets Heat Up Amid Falling Yields and AI Optimism SGX:ES3.SI:Straits Times Index STI SGX:D05.SI:DBS Group, SGX:U11.SI:UOB, SGX:O39.SI:OCBC SGX:ES3.SI:Straits Times Index STI STI Nears 4,000...

🏨 China Travel HK Soars Over 100% on Hotel Investment; Xiaomi, BYD, Pop Mart, Kuaishou, and JPMorgan in Focus

🏨 China Travel HK Soars Over 100% on Hotel Investment; Xiaomi, BYD, Pop Mart, Kuaishou, and JPMorgan in Focus HK:0308.HK:China Travel International Investment HK Ltd China Travel HK surged over 100% after China Tourism...

Bank of China Ltd (3988) Stock Analysis: Bullish Breakout Potential & Technical Buy Signal – June 2025 Hong Kong Retail Research

Broker: CGS International Date of Report: June 26, 2025 Bank of China Poised for Bullish Breakout: In-Depth Technical & Market Analysis for 2025 Market Overview: Navigating Unprecedented Headwinds in 2025 As global equity markets...

China Modern Dairy (1117 HK) Faces Short-Term Losses in 2025, Eyes Recovery as Raw Milk Prices Rebound | Analyst Report

Broker: China Galaxy International Securities (Hong Kong) Co., Limited Date of Report: June 24, 2025 China Modern Dairy Holdings Faces Short-Term Turbulence but Signals Recovery Ahead: In-Depth Financial Analysis and Outlook Overview: Challenging First...